1.795USD-2.46%Mkt Cap: 17.23M USDP/E: —Last update: 2026-06-01
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its lea…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap17.23M USD
Enterprise Value-1.17M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.44M USD
Revenue/Share—
Last Price1.795 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.76
PEG—
EV/EBITDA0.07
EV/Revenue—
P/S—
P/B0.81
EPS (TTM)-2.54
EPS (Forward)-1.06
52W Range
1.17018% of range4.560
52W High4.560 USD
52W Low1.170 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-70.54%
ROA-60.22%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.71M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-41.37%
Net Debt-19.59M USD
Net Debt/EBITDA1.10
Balance Sheet
Debt/Equity0.10
Current Ratio10.50
Quick Ratio10.17
Book Value/Sh2.313 USD
Cash/Share2.228 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJun 6, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)6.250 USD
Target Range4.000 USD – 10.00 USD
# Analysts4
Ownership
Shares Out.9.85M
Float7.03M
Insiders20.79%
Institutions38.12%
Short Interest
Short Ratio2.6d
Short % Float1.84%
Short % Out.1.64%
Shares Short161.81K
Short (prev mo.)350.15K
Technical
SMA 501.540 (+16.5%)
SMA 2001.883 (-4.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)66.98K
Avg Vol (10d)80.79K
Technical Indicators
RSI (14)65.6
MACD0.0616
MACD Signal0.0299
MACD Hist.+0.0317
BB Upper1.838 USD
BB Middle1.615 USD
BB Lower1.392 USD
BB Width27.59%
ATR (14)0.1031 USD
Vol Ratio (20d)0.85x